Ansøgningsnr. og dato | 17891529.4 (espacenet) (Federated) (European Patent Register), 20170113 | Patent/reg.nr. og dato | DK/EP 3569616, 20210929 | Tilgængelighedsdato | 20191120 | Prioritetsnr. og dato | | EP publ. nr. og dato |
EP 3569616 20191120 | Løbedag | | Ansøger/indehaver | Akeso Biopharma Inc., 6 Shennong Boulevard Torch Developmental Zone
Zhongshan, Guangdong 528437, CN, Taizhou Hanzhong Biopharmaceutics, Inc., No.1 of China Medical City Road
Taizhou, Jiangsu 225316, CN | Ansøgers ref. nr. | V352209DK00 | Opfinder | ZHANG, Faming, Biolake B6, Eastlake National High-Tech Development Zone
Wuhan, Hubei 430074, CN, XI, Gan, Biolake B6, Eastlake National High-Tech Development Zone
Wuhan, Hubei 430074, CN, HUANG, Ying, Biolake B6, Eastlake National High-Tech Development Zone
Wuhan, Hubei 430074, CN, XIA, Yu, 6 Shennong Blvd., Torch Development Zone
Zhongshan, Guangdong 528437, CN, LI, Baiyong, 6 Shennong Blvd., Torch Development Zone
Zhongshan, Guangdong 528437, CN, WANG, Zhongmin Maxwell, 6 Shennong Blvd., Torch Development Zone
Zhongshan, Guangdong 528437, CN | Fuldmægtig | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Interessent på tilknyttet sag | | IPC-Klasse | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C12N 15/13 (2006.01) | Titel/benævnelse | Monoklonalt antistof mod PD-1 og anvendelser deraf | Internationalt ansøgningsnr. | CN2017071125 | Internationalt publ. nr. | WO2018129714 | Relateret sag (certifikat) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|